OCUL
Price
$9.62
Change
+$0.16 (+1.69%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1.51B
39 days until earnings call
SPRY
Price
$16.52
Change
-$0.23 (-1.37%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
1.62B
34 days until earnings call
Interact to see
Advertisement

OCUL vs SPRY

Header iconOCUL vs SPRY Comparison
Open Charts OCUL vs SPRYBanner chart's image
Ocular Therapeutix
Price$9.62
Change+$0.16 (+1.69%)
Volume$99.04K
Capitalization1.51B
ARS Pharmaceuticals
Price$16.52
Change-$0.23 (-1.37%)
Volume$95.74K
Capitalization1.62B
OCUL vs SPRY Comparison Chart in %
Loading...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OCUL vs. SPRY commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a StrongBuy and SPRY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (OCUL: $9.62 vs. SPRY: $16.52)
Brand notoriety: OCUL and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 52% vs. SPRY: 61%
Market capitalization -- OCUL: $1.51B vs. SPRY: $1.62B
OCUL [@Biotechnology] is valued at $1.51B. SPRY’s [@Biotechnology] market capitalization is $1.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 5 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • OCUL’s TA Score: 5 bullish, 4 bearish.
  • SPRY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both OCUL and SPRY are a good buy in the short-term.

Price Growth

OCUL (@Biotechnology) experienced а +1.69% price change this week, while SPRY (@Biotechnology) price change was -8.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

OCUL is expected to report earnings on Aug 11, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRY($1.62B) has a higher market cap than OCUL($1.51B). SPRY YTD gains are higher at: 56.588 vs. OCUL (12.646). SPRY has higher annual earnings (EBITDA): -27.07M vs. OCUL (-176.35M). OCUL has more cash in the bank: 350M vs. SPRY (276M). SPRY has less debt than OCUL: SPRY (73K) vs OCUL (76.2M). SPRY has higher revenues than OCUL: SPRY (97.1M) vs OCUL (59.6M).
OCULSPRYOCUL / SPRY
Capitalization1.51B1.62B93%
EBITDA-176.35M-27.07M652%
Gain YTD12.64656.58822%
P/E RatioN/A151.25-
Revenue59.6M97.1M61%
Total Cash350M276M127%
Total Debt76.2M73K104,384%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCULSPRY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NOEMX12.98N/A
N/A
Northern Emerging Markets Equity Index
PJNQX60.78N/A
N/A
PGIM Jennison Natural Resources R6
MSPRX24.33N/A
N/A
Morgan Stanley Inst Advantage C
MEMAX38.36N/A
N/A
MFS Emerging Markets Equity A
TANDX38.37N/A
N/A
Castle Tandem No-Load

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+1.69%
EYPT - OCUL
58%
Loosely correlated
+0.62%
DNLI - OCUL
55%
Loosely correlated
-1.41%
NRIX - OCUL
52%
Loosely correlated
+2.33%
CRNX - OCUL
52%
Loosely correlated
+1.22%
RNA - OCUL
51%
Loosely correlated
-0.65%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-1.37%
LPCN - SPRY
63%
Loosely correlated
-0.32%
XOMA - SPRY
37%
Loosely correlated
+3.26%
ANAB - SPRY
35%
Loosely correlated
-0.54%
OCUL - SPRY
34%
Loosely correlated
+1.69%
RCUS - SPRY
34%
Loosely correlated
-1.40%
More